Evidence map›Paper›PMID 22080467›Full record

ArticleBioinformatics (Oxford, England)2012

Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers.

Edward Y Chen, Huilei Xu, Simon Gordonov, Maribel P Lim, Matthew H Perkins, Avi Ma'ayan

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 4 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 4 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Host andGut microbes · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Edward Y ChenDepartment of Pharmacology and Systems Therapeutics, Systems Biology Center New York, New York, NY, USA.
Huilei Xu
Simon Gordonov
Maribel P Lim
Matthew H Perkins
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai · US

Funding

VIRAL PATHOGENESIS OF HIV ASSOCIATED NEPHROPATHYP01DK056492 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI KLOTMAN, PAUL EVAN · 1999 to 2021
$27.8M
System Biology Center in New YorkP50GM071558 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZAPH, SUSANA NEVES · 2007 to 2017
$22.8M
Role of HIPK2 in Kidney Tubulointerstitial InjuryR01DK088541 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HE, JOHN CIJIANG · 2010 to 2019
$4.0M
A Chemical Biology Network for Personalized MedicineRC2LM010994 · NLM · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARDOZO, TIMOTHY J, MA'AYAN, AVI · 2010 to 2010
$2.1M
RNA profiling of HIV-associated nephropathy in patients with the MYH9 risk alleleRC4DK090860 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI KLOTMAN, PAUL EVAN · 2010 to 2010
$1.9M
Mount Sinai Institutes for Clinical and Translational SciencesKL2RR029885 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MURPHY, BARBARA T. · 2009 to 2011
$1.8M
Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory LayersR01GM098316 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MA'AYAN, AVI · 2012 to 2015
$1.3M
NCRR NIH HHS KL2RR029885-0109NIDDK NIH HHS P01 DK056492NIDDK NIH HHS P01DK056492-10NIDDK NIH HHS R01 DK088541NIDDK NIH HHS R01DK088541-01A1NIDDK NIH HHS RC4 DK090860NIDDK NIH HHS RC4DK090860-01NIGMS NIH HHS P50 GM071558NIGMS NIH HHS P50GM071558-03NIGMS NIH HHS R01 GM098316NLM NIH HHS RC2 LM010994NLM NIH HHS RC2LM010994-01
6 · The paper itself

Abstract

motivationGenome-wide mRNA profiling provides a snapshot of the global state of cells under different conditions. However, mRNA levels do not provide direct understanding of upstream regulatory mechanisms. Here, we present a new approach called Expression2Kinases (X2K) to identify upstream regulators likely responsible for observed patterns in genome-wide gene expression. By integrating chromatin immuno-precipitation (ChIP)-seq/chip and position weight matrices (PWMs) data, protein-protein interactions and kinase-substrate phosphorylation reactions, we can better identify regulatory mechanisms upstream of genome-wide differences in gene expression. We validated X2K by applying it to recover drug targets of food and drug administration (FDA)-approved drugs from drug perturbations followed by mRNA expression profiling; to map the regulatory landscape of 44 stem cells and their differentiating progeny; to profile upstream regulatory mechanisms of 327 breast cancer tumors; and to detect pathways from profiled hepatic stellate cells and hippocampal neurons. The X2K approach can advance our understanding of cell signaling and unravel drugs mechanisms of action. AVAILABILITY: The software and source code are freely available at: http://www.maayanlab.net/X2K. CONTACT: avi.maayan@mssm.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Gene Expression ProfilingGenome-Wide Association StudyRegulatory Sequences, Nucleic AcidSoftwareAnimalsCell DifferentiationChromatin ImmunoprecipitationHumansOligonucleotide Array Sequence AnalysisSignal TransductionTranscription FactorsTranscription Factors

Identifiers

PMID22080467
PMCPMC3244772
OpenAlexW2100786079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.